Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Diclofenac significantly increases cardiovascular risk, large study suggests | MIMS online
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Use of Nonsteroidal Antiinflammatory Drugs | Circulation
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update | SpringerLink
Diclofenac (Voltaren) and risk of cardiovascular events (heart attack and stroke)
DICLOFENAC SODIUM
NSAIDS and Cardiovascular Risk - Sports Medicine Review
Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library
Common painkiller linked to an increased risk of heart problems
NSAIDs: Medicines involved | Medicines Safety Portal
Cardiovascular effects and safety of (non-aspirin) NSAIDs | Nature Reviews Cardiology
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | SpringerLink
Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries – topic of research paper in Economics and business.
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
Diclofenac sodium vs Voltaren | Power
An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs - ScienceDirect
Ibuprofen and cardiovascular safety
Diclofenac: Package Insert - Drugs.com
Eric Topol on X: "Bad news on diclofenac (Voltaren), a commonly used anti-inflammatory, with heart risks in excess of acetaminophen, naproxen and ibuprofen https://t.co/pXNzV5vCv4 @bmj_latest open-access by @Morten__Schmidt @ToftSorensen @Lars_HP ...
